We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:CYTK

Cytokinetics, Incorporated (CYTK)

Nasdaq • CYTK • US23282W6057

63.60Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimated 14% of free float sold short, 9.6 days to cover, cost to borrow 0.56%. Sign up for live short interest data.

Market Cap

8.92b USD | # 1742 in US

Volume

1.91m shares | 131.59m USD

Shares Outstanding

139.02m

Free Float Shares

99.62% | 138.49m

DB:KK3A|

XTRA:KK3A|

News

CYTK key data

Cytokinetics, Incorporated (Nasdaq: CYTK) has a market capitalization of $8.92B. Last close $63.60 (as of 2026-11-05); 52-week range $58.05 to $88.31. ORTEX data as of 2026-10-21: short interest was 13.99% of free float, 9.6 days to cover and the average cost to borrow was 0.56%. Sign up for live short interest data.

CYTK news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.